Acs Fall 2024 Vvd-130037 Vvd1300374

Acs Fall 2024 Vvd-130037 Vvd1300374. Current such mutations include the following: Choose from thousands of presentations, network, attend courses and visit the expo.


Acs Fall 2024 Vvd-130037 Vvd1300374

Vividion has already disclosed work on covalent keap1 inhibitors, but at the recent acs fall 2024 meeting, the structure and discovery story of their clinical oral covalent activator of. Technical sessions, networking, career development & more.

Acs Fall 2024 Vvd-130037 Vvd1300374 Images References :